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The Editorial on the Research Topic
Neurodegeneration: from Genetics to Molecules
This research topic gives an overview of the current knowledge on some of the most common
processes in neurodegenerative diseases such as Alzheimer, Parkinson and Temporal Lobe Epilepsy.
Here we reviewed different aspects of each neurodegenerative process, including epigenetics,
oxidative and inflammatory responses, genetic susceptibility, aging, metals and environmental
exposure, autophagy, and micro RNA basic research.
Neurodegeneration: from genetics to molecules, is a multidisciplinary research topic aiming to
be of interest to basic researchers in medical fields.
Many expected that the splendid and remarkable success of the human genome project
introduced toward the end of the Twentieth century would halt the epidemic of neurodegenerative
diseases. Yet, rather than diminished, it has risen to become a serious problem of morbidity, loss
of useful life years, and mortality worldwide. Simultaneously, laboratory research has continued to
unravel successive layers of the pathophysiology of neurodegenerative diseases and themechanisms
of its clinical complications, suggesting new routes to follow for the development of innovative
therapeutic approaches.
Hence, the need for a compendium of articles that reviews the current state-of-the-art
of neurodegeneration research spanning from a global perspective to fundamental molecular
mechanisms. The editors intended this collection of articles in order to highlight the emerging
challenges to many tenets of belief that have emerged from recent studies. We do so in the
spirit of inspiring future research to attack the unresolved questions and to exploit the newer
discoveries that have opened unanticipated horizons of understanding and raised novel questions
and opportunities for therapies.
Calero et al. commence the research topic with an update of additional mechanisms conferring
genetic susceptibility to Alzheimer’s disease. They describe the analysis of mutations in the
genes involved in the production of the amyloid related to EOFAD. In addition, they review
the genes associated to LOAD and the list of genes associated with sporadic AD. Further,
they analyze recent whole-exome studies looking for strong association to the disease, and
integrate several studies dealing with epistasis as additional mechanisms conferring genetic
susceptibility to AD, searching for networks rather than the contribution of specific genes
(Calero et al).
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Landgrave-Gómez et al. reviewed the role of epigenetic
mechanisms in the function and homeostasis of the central
nervous system and their participation in a variety of
neurological disorders. The evidence suggests that long-term
changes in gene transcription could be associated with changes
in chromatin structure and participate in a variety of neurological
disorders (Landgrave-Gomez et al).
Chin-Chan et al. evaluated the environmental pollutants
as risk factors for Alzheimer (AD) and Parkinson diseases
(PD). They discuss the role of environmental factors such
as lead, mercury, aluminum, cadmium and arsenic, as well
as some pesticides and metal-based nanoparticles in the
development of idiopathic AD and PD, and their mechanisms of
action.
Ramos-Chávez et al. reviewed the neurological effects of
inorganic arsenic (iAs) exposure as an important natural
pollutant. They investigate the effects of gestational iAs
exposure and evaluate the expression of the cysteine/glutamate
transporters in cortex and hippocampus, demonstrating
significant differences in spatial memory impairment in males
while the effect was marginal in females (Chin-Chan et al).
Sankowski et al. examined the relationship of systemic
inflammation and the brain, looking for novel roles of
genetic, molecular, and environmental cues as drivers of
neurodegeneration. The CNS responds to somatic and
autonomic sensory information, also receiving input from
the periphery about inflammation and infection. The hypothesis
is that the resulting translocation of inflammatory mediators
can interfere with neuronal and glial homeostasis. Here, they
review recent genetic evidence suggesting an association between
neurodegenerative disorders and persistent immune activation
and evaluate their potential relevance in neurodegenerative
disorders (Sankowski et al).
Joshi and Pratico reviewed the 5-lipoxygenase (5LO) and
its downstream leukotriene metabolites as oxidative and
inflammatory contributions to Alzheimer’s disease. 5LO pathway
and 5LO activating protein (FLAP) have been implicated in
the molecular pathology of AD, including the metabolism of
amyloid-β and tau. In this article you will find an overview of 5LO
and FLAP, discussing their involvement in biochemical pathways
relevant to AD pathogenesis and how targeting these proteins
could lead to therapies relevant not only for AD, but also other
related neurodegenerative conditions (Joshi and Pratico).
Toral-Rios et al. evaluated the relationship of polymorphisms
of inflammation-related genes with Alzheimer’s disease. Since
it has been demonstrated that inflammation contributes to the
process of neurodegeneration and therefore being a key factor
in the development of AD, the authors evaluate the differences
in frequencies between AD and controls by single-nucleotide
polymorphism (SNP) of inflammation-related genes (Toral-Rios
et al).
James et al. analyzed aged neuronal nitric oxide knockout
mice. The animals show preserved olfactory learning suggesting
that lack of NO releases protected animals against age-associated
cognitive decline in memory tasks typically involving olfactory
and hippocampal regions, but not against declines in reversal
learning or locomotor activity (James et al).
Blanco Ayala et al. studied an alternative kynurenic
acid synthesis route in the rat cerebellum. The Kynurenic
acid (KYNA) is an endogenous antagonist of α7 nicotinic
acetylcholine and excitatory amino acid receptors. Their results
suggest that different mechanisms are involved in KYNA
production in the rat cerebellum and that, specifically, DAAO
and ROS can function as alternative routes for KYNA synthesis
(Blanco Ayala et al).
Phillips-Farfán et al. demonstrated that caloric restriction
(CR) has a protective effect against amygdala electrical kindling
by inhibiting the mTOR signaling pathway. They investigated
whether CR altered the levels of insulin and energy substrates.
And found that CR decreases protein kinase B phosphorylation
and ribosomal protein S6, suggesting an inhibition of the mTOR
cascade as well as an increasing after-discharge threshold tending
to reduce the after-discharge duration. It suggests an anti-
convulsive action which could imply that CR has an anti-epileptic
effect via inhibition of the mTOR pathway (Phillips-Farfan et al).
Lucas et al. found cerebellar transcriptional alterations
with Purkinje cell dysfunction and loss in mice lacking
the transcriptional coactivator peroxisome proliferator-activated
receptor γ coactivator-1α (ppargc1a or PGC-1α). The authors
found that mice lacking PGC-1α exhibit ataxia in addition
to deficits in motor coordination. Their data suggest that
dysfunction in multiple cell types contributes to motor deficits
in the context of PGC-1α deficiency (Lucas et al).
Braidy et al. evaluated the differential expression of sirtuins in
aging rat brains. They tested mRNA and protein expression levels
of rat SIRT1-7, and levels of associated proteins in the brain using
RT-PCR and western blotting. This article identifies important
unknown roles for sirtuins in regulating cellular homeostasis and
healthy aging (Braidy et al).
da Luz et al. found that dopamine induces the accumulation
of insoluble prion protein and affects autophagic flux. Since
dopamine metabolism generates several oxidative metabolites
and can be highly reactive, the authors investigated whether these
molecules can also affect the aggregation of cellular prion protein
(PrPC). Their results bring new insight into the dopamine
metabolism as a source of endogenous metabolites capable of
altering PrPC solubility and its subcellular localization (da Luz
et al).
Rocha et al. studied the GABAergic alterations in neocortex
of patients with pharma-co-resistant temporal lobe epilepsy and
explain the comorbidity of anxiety and depression. Their results
showed a dysfunction of the GABAergic neurotransmission in
temporal neocortex of patients with Temporal Lobe Epilepsy and
comorbid anxiety and/or depression that could be also influenced
by clinical factors such as seizure frequency and duration of
illness (Rocha et al).
Mielcarek et al. evaluated histone deacetylase 4 as a potential
therapeutic target in neurodegenerative diseases. HDAC4 is a
member of the class IIa family of histone deacetylases and is
the major player in synaptic. In this review the authors integrate
the information regarding the biological role of HDAC4 in
neurodegenerative processes (Mielcarek et al).
Carballo-Molina and Velasco evaluated the hydrogels as
scaffolds and delivery systems to enhance axonal regeneration
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after injuries. As hydrogels are biodegradable, biocompatible and
have the capacity to deliver a large range of molecules in situ, they
have been used in several biomedical applications. This review
discusses areas of opportunity where hydrogels can be applied,
in order to promote axonal regeneration of the NS, by applying
hydrogels in combination with cultured neural cells, forming
three-dimensional structures, showing the formation of synapses
and neuronal survival (Carballo-Molina and Velasco).
Garza-Manero et al. performed the identification of age- and
disease-related alterations in circulating miRNAs in a mouse
model of Alzheimer’s disease. In this study the authors evaluated
the levels of miRNA at different time-points in a transgenic
mouse model of Alzheimer disease (3xTg-AD). They found age-
related significant changes in miRNA abundance for both WT
and transgenic mice. Some of these were specific for the 3xTg-
AD, suggesting that the age-dependent evolution of the AD-
like pathology, rather than the presence and expression of the
transgenes, modifies the circulating miRNA levels in the 3xTg-
AD mice (Garza-Manero et al).
Correa-Basurto et al. using molecular dynamics and docking
simulations, realized the identification of the antiepileptic
racetam binding site in the synaptic vesicle protein 2A
(SV2A). SV2A is the molecular target of the anti-epileptic
drug levetiracetam and its racetam analogs. The importance of
this study is that identifying the racetam binding site within
SV2A will facilitate the synthesis of new radio-ligands to
improve treatment response and evaluate epilepsy progression
(Correa-Basurto et al).
Acquarone et al. studied in a mouse model of Parkinson’s
disease (PD), mitomycin-treated undifferentiated embryonic
stem cells as a safe and effective cellular therapeutic strategy.
The authors show that undifferentiated mouse embryonic stem
cells (mESCs), pre-treated with mitomycin C (MMC) before
transplantation, prevented tumorigenesis in a 12 week follow-up
after mESCs were injected in nude mice and in 6-OH-dopamine-
lesioned mice. Intrastriatal injection of MMC-treated mESCs
markedly improved motor function without tumor formation.
These findings show novel strategies for cell therapies and
particularly for treatment of PD (Acquarone et al).
González-Castillo et al. reviewed the role of pleiotrophin
(PTN) as a central nervous system (CNS) neuromodulator.
In this paper, the authors highlight and summarize the most
recent advances and results that lead to proposing a PTN as
a neuromodulatory molecule in the CNS, particularly in the
hippocampus. Interesting data in CNS demonstrate that PTN
exerts post-developmental neurotrophic and -protective effects,
and recently has been involved in neurodegenerative diseases and
neural disorders (Gonzalez-Castillo et al).
Gonzalez-Lima et al. provided an update on the cellular
mechanisms mediating the neuroprotective effects of low doses
of methylene blue and near-infrared light. In addition the authors
demonstrate how the neurotherapeutic benefits of these two
different interventions share the same cellular mechanism of
action. Highlighting the similarities in energy transfer, low-dose
hormetic dose-responses, and enhanced capacity for oxidative
metabolic energy production (Gonzalez-Lima and Auchter).
Szabadfi et al. analyzed the retinal aging phenomena in the
diurnal Chilean rodent (Octodon degus). Their results show
overexpression of GFAP in Müller glial cells in aging retinas and
a reduction in the number of rod bipolar cells and the ganglion
cells while that of cone bipolar cells remained unchanged. Their
results are very interesting adding novel data to understand the
retinal aging process (Szabadfi et al).
Finally, we recognized that a single collection of articles
cannot deal with the extremely large number of topics
that characterize a complex multifactor condition such as
neurodegeneration. The topics addressed, however, help
developing a clear idea, not only of what has been obtained
to date by previous studies but also of the unmet needs future
research should focus on. We trust that the papers assembled in
this research topic will prove useful in spurring and stimulating
this future progress.
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